Acorda Therapeutics, Inc.
CARBONATE PRODRUGS AND METHODS OF USING THE SAME

Last updated:

Abstract:

The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.

Status:
Application
Type:

Utility

Filling date:

1 Jul 2019

Issue date:

21 May 2020